Replenish Nutrients Bets on New Partnership to Boost Market Profile

OKOTOKS, AB – February 23, 2026 – In a strategic move to amplify its voice in a crowded market, regenerative agriculture firm Replenish Nutrients Holding Corp. (CSE: ERTH) (OTC: VVIVF) has engaged Sophic Capital Inc., a Toronto-based advisory firm, to spearhead its investor relations and capital markets strategy. The announcement signals a pivotal moment for the micro-cap company as it seeks to translate its sustainable technology into significant shareholder value.

Replenish, which has a market capitalization hovering around C$20 million, is navigating the often-turbulent waters of the Canadian Securities Exchange and OTC markets—a common challenge for growth-stage companies striving for visibility. By retaining Sophic Capital, a firm specializing in small-cap growth stories, Replenish is making a calculated investment to better articulate its value proposition to a broader audience of institutional and retail investors.

A Strategic Push for Visibility

The partnership, set for an initial 12-month term, is designed to address a core challenge for companies like Replenish: communicating a complex, science-based business model to the financial community. Sophic Capital's mandate includes heightening market awareness and implementing a communications strategy to broaden the company's reach.

"We are entering an exciting phase of growth as we scale our regenerative fertilizer platform through both owned production and capital-light licensing partnerships," said Neil Wiens, CEO of Replenish, in the official announcement. He emphasized that Sophic Capital's experience and investor network are key assets that "will help us more effectively communicate our value proposition and long-term vision to the investment community."

This sentiment was echoed by Sean Peasgood, CEO of Sophic Capital, who highlighted the compelling nature of Replenish's story. "The Company is addressing a large and evolving agricultural market with patented technology, demonstrated commercial traction, and a scalable licensing model," he commented. Peasgood expressed confidence that this narrative will resonate with Sophic Capital's network, which is attuned to clean technology and special situations.

For a fee of $8,000 per month, plus a grant of 1.25 million stock options exercisable at $0.12 per share, Sophic Capital is heavily incentivized to deliver results. This structure, combining a cash retainer with equity incentives, is standard practice for aligning the interests of an advisory firm with its client's long-term success. The option exercise price is notably close to ERTH's recent trading price, providing an immediate incentive to drive stock appreciation.

Betting on a Greener Future

At the heart of this new push for investor attention is Replenish Nutrients' core business: manufacturing proprietary fertilizers that aim to heal the soil. The company operates in the burgeoning field of regenerative agriculture, which focuses on improving soil health and biodiversity rather than simply extracting value from it. Using a proprietary zero-waste manufacturing process, Replenish creates products with essential macro and micronutrients designed as a sustainable alternative to traditional synthetic fertilizers.

This mission aligns perfectly with the growing ESG (Environmental, Social, and Governance) investment trend, where investors are increasingly deploying capital into companies that promise both financial returns and positive environmental impact. The global agricultural market is under pressure to become more sustainable, creating a significant opportunity for innovators like Replenish.

Despite its promising technology, the company's financial performance has been mixed, reflecting the realities of a growth-stage enterprise. Unaudited financials from earlier in its fiscal year showed a year-over-year revenue decrease, with a net loss of $1.6 million compared to $0.3 million in the prior-year period. However, the same reports noted an increase in gross profit and growing sales volumes to third-party customers, suggesting that underlying demand for its products is strengthening. This commercial traction is a key pillar of the investment thesis Sophic Capital will be tasked with building.

Navigating a Volatile Market

The decision to engage an investor relations firm comes as Replenish's stock exhibits the volatility typical of its class. Over the past year, its CSE-listed shares (ERTH) have seen a significant run-up, moving over 100% at one point, but have also experienced short-term pullbacks. The stock has traded in a 52-week range between $0.065 and $0.255, a wide band that underscores both its potential and its risk. Analyst consensus, however, appears optimistic, with an average target price of C$0.45, suggesting a substantial upside from its current levels if the company can execute its strategy.

This partnership is fundamentally about managing that narrative and reducing the volatility by building a stable base of long-term investors who understand the company's vision. By proactively communicating milestones—such as the planned upgrades to its Beiseker facility to boost production capacity—the company hopes to bridge the gap between its current market valuation and its future potential.

The competitive landscape for agricultural technology is fierce, with players like Bioceres Crop Solutions (NasdaqGS:BIOX) and N2OFF (NasdaqCM:NITO) also vying for market share and investor capital. Replenish’s emphasis on a scalable, capital-light licensing model, in addition to its owned production, could be a key differentiator. This dual approach allows for potentially faster market penetration without the massive capital expenditure typically required for manufacturing expansion. Communicating this nuanced strategy effectively will be a primary task for its new IR partners.

Ultimately, the success of this engagement will be measured over the next 12 months. Investors will be watching closely to see if the collaboration with Sophic Capital translates into increased trading volume, a more stable and appreciative stock price, and, most importantly, the capital required to fuel the next stage of Replenish Nutrients' growth in the vital regenerative agriculture sector.